DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
Clinical trials for DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B CELL LYMPHOMA (DLBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Tough-to-Treat blood cancers
Disease control TerminatedThis study tested a new antibody drug called GEN3014 in people with multiple myeloma and other blood cancers that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the drug showed early signs of helping control the cance…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Gene-Edited immune cells take aim at stubborn lymphoma
Disease control TerminatedThis early-stage study tested a new type of CAR T-cell therapy called bbT369 in adults with aggressive B-cell lymphoma that had come back or not responded to at least two prior treatments. The therapy involves modifying a patient's own immune cells to better target and fight the …
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for patients out of options: experimental drug enters first human trials
Disease control TerminatedThis early-stage study tested a new drug called voruciclib, both alone and combined with another drug (venetoclax), in adults with advanced blood cancers like leukemia and lymphoma. The main goal was to find safe dosage levels and see if the treatment showed any early signs of he…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
Phase: PHASE1 • Sponsor: MEI Pharma, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC